作者：
Jingjing,Zhang [1]
;
Aviral,Singh [1]
;
Harshad R,Kulkarni [1]
;
Christiane,Schuchardt [1]
;
Dirk,Müller [1]
;
Hans-J,Wester [2]
;
Theodosia,Maina [3]
;
Frank,Rösch [4]
;
Nicholas P,van der Meulen [5]
;
Cristina,Müller [6]
;
Helmut,Mäcke [7]
;
Richard P,Baum [8]
作者单位：
THERANOSTICS Center for Molecular Radiotherapy and Precision Oncology, Zentralklinik Bad Berka, Bad Berka, Germany.
[1]
Institute for Radiopharmaceutical Chemistry, Technische Universität München, Garching, Germany.
[2]
Molecular Radiopharmacy, INRASTES, NCSR "Demokritos", Athens, Greece.
[3]
Institute of Nuclear Chemistry, Johannes Gutenberg-University, Mainz, Germany.
[4]
Center for Radiopharmaceutical Sciences, ETH-PSI-USZ, Paul Scherrer Institute, Villigen, Switzerland; (
[5]
)Laboratory of Radiochemistry, Paul Scherrer Institute, Villigen, Switzerland.
[6]
Center for Radiopharmaceutical Sciences, ETH-PSI-USZ, Paul Scherrer Institute, Villigen, Switzerland.
[7]
Department of Nuclear Medicine, University Hospital of Freiburg, Freiburg, Germany.
[8]
THERANOSTICS Center for Molecular Radiotherapy and Precision Oncology, Zentralklinik Bad Berka, Bad Berka, Germany. Electronic address: richard.baum@zentralklinik.de.
[9]
DOI
10.1053/j.semnuclmed.2019.06.002
PMID
31470935
发布时间
2021-12-04
换一批
换一批
